Antioxidants may unlock sex differences in brain blood flow
NCT ID NCT05958303
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study investigates how sex and stress influence blood flow in the brain, and whether antioxidants can alter that regulation. Healthy adults aged 18 to 40 will take either an antioxidant cocktail or a placebo, then undergo MRI scans to measure brain blood flow under normal and high-oxygen conditions. The goal is to understand basic mechanisms that could one day inform treatments for conditions like stroke or vascular dementia.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Antioxidant Cocktail (vitamin C, vitamin E, alpha lipoic acid)
- What this could lead to
- If successful, this could reveal why men and women differ in brain blood flow regulation, potentially guiding future treatments for cerebrovascular disorders.
- What could go wrong
- This is a small, early-stage study in healthy volunteers, so findings may not apply to people with health conditions. The antioxidant effects may be modest or absent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
24 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between ≥18 - ≤40 years Exclusion Criteria: * Hypertensive * \>125 mmHg systolic blood pressure; or * \>80 mmHg diastolic blood pressure * BMI ≥25 kg/m2 * Fasting blood glucose ≥100 mg/dl * LDL cholesterol ≥130 mg/dl * Triglycerides ≥150 mg/dl * Current diagnosis or history of: * peripheral vascular disease * hepatic disease * renal disease * lung disease * gastrointestinal disorders/bleeding * hematologic disease * stroke * myocardial infarction * coronary heart disease * congestive heart failure * heart surgery * prediabetes * diabetes mellitus (type 1, type 2, MODY, or others) * sleep apnea * hypertension * some autoimmune diseases, such as inflammatory bowel disease or systemic lupus erythematosus (exclusion at discretion of reviewing MD) * Current smoking, defined as the use of tobacco or nicotine products \>5 times in the past 30 days. * Cardiovascular medication use * NSAID sensitivity * Any contraindications of having an MRI o (e.g. the requirement of anxiolytics in order to complete an MRI scan) * Irregular menstrual cycle (females only) * Medical conditions that can affect the menstrual cycle, such as hyperprolactinemia, prolactinoma, hypercortisolemia, and congenital adrenal hyperplasia (females only) * Pregnancy, breast feeding, or plans to conceive within the next 3 months (females only) * Polycystic ovary syndrome (females only) * Hirsutism defined as unwanted and/or excessive hair growth on the face, chest, or back (females only) * Levonorgestrel intrauterine device (IUD) (females only) * Hormonal birth control will not be allowed in women, in order to control for high variability between type, dose, and route of therapy. However, in discussion with Dr. Davis (Co-I) and Dr. Laura Cooney M.D., physician experts in medical and reproductive endocrinology and infertility, there are two broad exceptions to this birth control criteria: 1. Copper intrauterine devices (IUDs) will be allowed as they do not change systemic sex hormone levels). 2. Women currently taking hormonal birth control (i.e. contraceptive pills, patch, ring) for contraception only (not for a medical condition such as those listed in exclusion criteria above) may consider temporarily stopping to become eligible for enrollment. Hormonal birth control must be stopped at least one month prior to Study Visit 1 to provide time for menstruation to resume. Then stoppage continues through the last planned study visit. Screening information will be reviewed by endocrinology physicians to determine eligibility and timing on this issue (details below).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cerebrovascular disorders are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Nature's shield for the aging brain? plant compound tested against vascular cognitive decline
- Blood's tiny RNA clues could unlock the stroke 'Clock'
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Free meds could boost quit rates in stroke survivors
- AI crystal ball: can machine learning forecast stroke recovery?
- Stroke ambulance trial aims to cut disability from brain bleeds